Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder
about
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.Spotlight on differentially expressed genes in urinary bladder cancer.Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.Biological markers in the diagnosis of recurrent bladder cancer: an overview.High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis.Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Noninvasive approaches for detecting and monitoring bladder cancer.In vitro screening for drug-induced depression and/or suicidal adverse effects: a new toxicogenomic assay based on CE-SSCP analysis of HTR2C mRNA editing in SH-SY5Y cells.Palliative Vitamin C Application in Patients with Radiotherapy-Resistant Bone Metastases: A Retrospective Study.SPOCK1 promotes tumor growth and metastasis in human prostate cancer.Plasma levels of matrix metalloproteinases 2 and 9 correlate with histological grade in breast cancer patientsSequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.
P2860
Q33649673-653002C9-136A-4F99-B512-4B390EBE5CDCQ33869194-B80B8FC6-8D84-4030-88A3-60531FE5DD56Q34405818-A6F1CEA8-1B12-4C94-B2B5-E6D311325D5BQ34500862-06F26D58-2A91-45E4-AC0C-5B504FBA4B14Q34824216-59B28FC4-C705-4635-8187-5B84DEE366C9Q35934764-8EF933C3-5AA6-45AA-8664-0D8A5F26F122Q37035277-59CF7DBA-D21A-48C1-A44B-41BFF807EA90Q37321347-5E3BC18F-6C9D-46D4-9CBA-B2B6F3F2E587Q38196442-AA1D3B95-4D22-4C9A-BDDB-A41F2CAC3C90Q38286089-52427E23-C1D3-4861-B30B-2443036EC2B2Q39360061-B2E2BBF9-AE0E-49F4-89FB-570C7AB66151Q41592056-96427F01-3F59-4642-80A3-AA29E5AD306DQ42407534-9FF19636-26A6-4F3D-A2B2-B2B8B42FBA98Q42416955-3D28F4D2-0778-4476-B791-68DFC7031557Q46289482-F93E2574-6A39-4E0A-8771-261439ACAD1F
P2860
Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combined determination of plas ...... cell carcinoma of the bladder
@ast
Combined determination of plas ...... cell carcinoma of the bladder
@en
type
label
Combined determination of plas ...... cell carcinoma of the bladder
@ast
Combined determination of plas ...... cell carcinoma of the bladder
@en
prefLabel
Combined determination of plas ...... cell carcinoma of the bladder
@ast
Combined determination of plas ...... cell carcinoma of the bladder
@en
P2093
P2860
P356
P1433
P1476
Combined determination of plas ...... cell carcinoma of the bladder
@en
P2093
Andrea Staack
Dietmar Schnorr
Stefan A Loening
Steffen Badendieck
P2860
P2888
P356
10.1186/1471-2490-6-19
P50
P577
2006-08-10T00:00:00Z
P5875
P6179
1002101133